Dosing and therapeutic drug monitoring of tinzaparin on the pediatric intensive care unit

eiden University Medical Center (LUMC), Department of Pediatric Intensive Care0 个研究点目标入组 50 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

阶段: 不适用
状态: Other
发起方
入组人数: 50

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

Roeleveld P.P. et al; Higher Tinzaparin Dosing Is Needed to Achieve Target Anti-Xa Levels in Pediatric Cardiac Intensive Care Patients. Pediatric Critical Care Medicine, January 2016.

研究设计

研究类型: Observational

入排标准

入选标准

•Patients on the pediatric intensive care unit with tinzaparin as therapeutic anticoagulation

排除标准

•- Patients with tinzaparin as profylactic anticoagulation
•- Patients with an coagulation disorder

研究者

发起方

eiden University Medical Center (LUMC), Department of Pediatric Intensive Care

相似试验

招募中

不适用

Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in ChildrenAspergillosis InvasiveMucormycosis

NCT06440915Shanghai Children's Medical Center200

Unknown

1 期

Safety and Pharmacokinetics of Piperacillin-tazobactam Extended Infusion in Infants and Children (PIP-TAZO)Infection

NCT02466438St. Justine's Hospital141

已完成

4 期

Low and High Dose Zonisamide in Children as MonotherapyEpilepsy

NCT01127165Eisai Korea Inc.125

已完成

不适用

Zinc Dosing Trial - Does Dose Reduction Reduce Side Effects But Retain Efficacy in Diarrhoea ManagementDiarrhea

NCT03078842Ayesha De Costa4,500

已完成

2 期

A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum MalariaMalaria,Falciparum

NCT01992900sigma-tau i.f.r. S.p.A.300